Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 2, 2003rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes
-
Oct 16, 2003Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live
-
Sep 23, 2003Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer
-
Sep 15, 2003Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology
-
Jul 31, 2003Insmed Incorporated Reports Improved Financial Results for Second Quarter and First Half of 2003
-
Jul 24, 2003Insmed Incorporated to Webcast Second Quarter Earnings Conference Call; Thursday, July 31, at 11:00 a.m. ET - 10:00 a.m. CT
-
Jul 16, 2003Insmed Inc. Conludes Private Placement Led by Wells Fargo Securities Raising $1.9 Million More Than Previously Reported
-
Jul 14, 2003Insmed Reports Positive Data to AACR with rhIGFBP-3 in Cancer
-
Jul 11, 2003Insmed Inc. Raises $12 Million in Private Placement of Common Stock Lead by Wells Fargo Securities
-
Jul 9, 2003Insmed Incorporated to Present Positive Oncology Data On rhIGFBP-3 at the Annual Meeting of the American Association of Cancer Research
-
Jun 23, 2003Insmed Launches Pivotal Phase III Clinical Trial in GHIS; Data Analysis Planned for Early 2004
-
Jun 20, 2003Insmed Presents Positive Data on Lead Drug Candidate at Endocrine Society Annual Meeting; Study Shows Advantages of Company's rhIGF-I/rhIGFBP-3 In Treating Growth Disorder
-
Jun 20, 2003Insmed Receives European Orphan Drug Designation For rhIGF-I/rhIGFBP-3; Product Will Have 10 Years of Market Exclusivity in Treatment of Growth Disorder
-
Jun 19, 2003Insmed Announces Management Reorganization; Ronald D. Gunn Promoted to Executive VP; Lewis Stuart Departs as VP Commercial Development
-
Jun 18, 2003Insmed to Present Lead Drug Candidate at the Endocrine Society Annual Meeting
-
Jun 17, 2003Insmed Selected to Present to BIO 2003 Business Forum; Presentation to be Webcast Live
-
Jun 12, 2003Insmed to Report Positive Effects of rhIGF-I/rhIGFBP-3 In Adolescent Subjects with Type 1 Diabetes
-
Jun 2, 2003Insmed Presents Data To ASCO Highlighting Potential Benefit Of rhIGFBP-3 in Cancer; rhIGFBP-3 Shown to Enhance Chemotherapy in Models of Human Breast Cancer
